EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

Saved in:

Bibliographic Details
Main Authors:	Nico van Zandwijk, Alexandre Mathy, Lucie Boerrigter, Henrique J. Ruijter, Ivon H. G. Tielen, Daniëlle de Jong, Paul Baas, Sjaak A. Burgers, Petra M. Nederlof
Format:	Artigo
Language:	English
Published:	2006
Online Access:	https://doi.org/10.1093/annonc/mdl323
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1093/annonc/mdl323